0.00Open0.10Pre Close0 Volume20 Open Interest245.00Strike Price0.00Turnover3584.85%IV11.68%PremiumApr 11, 2025Expiry Date0.00Intrinsic Value100Multiplier-8DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0136Delta0.0017Gamma2772.90Leverage Ratio-223.1404Theta0.0000Rho-37.83Eff Leverage0.0002Vega
Amgen Stock Discussion
Gapping Up
$Hertz Global (HTZ.US)$ soared 17.2%, building on the previous session's momentum. On Wednesday, the stock had already jumped over 56% after Bill Ackman's Pershing Square revealed a significant investment in the company.
$Eli Lilly and Co (LLY.US)$ surged 10.8% in Thursday's premarket trading following the company's announcement that its oral GLP-1 receptor agonist, orforglipron, achieved the primary endpoi...
Breakthrough: New Cancer Drug IMDELLTRA Outperforms Standard Treatment in Survival Study
Gapping Up
$Peabody Energy (BTU.US)$ shares extended gains to 11.10% in pre-market trading after a 9.2% rise yesterday, following President Trump's executive orders aimed at reviving the U.S. coal industry. Trump plans to use the Defense Production Act to support coal mining and next-generation technologies, and instruct the DOJ to challenge regulations affecting coal jobs, aiming to enhance U.S. AI leadership by b...
On Monday, Trump suggested that he would be “very kind...
Can This New Atopic Dermatitis Drug Challenge Current Market Leaders? Phase 3 Data Reveals Key Insights
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
AMGN, MRNA, PFE, JNJ ARE SAME BUS OR NOT = AMGN, MRNA, PFE, JNJ SEM BUT ZAY KO 🤔
Market worries over the tariffs focus on two key issues. U.S. companies that depend heavily ...
No comment yet